Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein ReceptorDouglas G. Johns, Harold B. Wood, Thomas J. Tucker et al.|Circulation|2023Cited by 141
A New Strategy for Rapidly Screening Natural Inhibitors Targeting the PCSK9/LDLR Interaction In VitroLi Li|Molecules|2018Cited by 15